Parents' views of cancer-directed therapy for children with no realistic chance for cure

被引:73
作者
Mack, Jennifer W. [1 ]
Joffe, Steven
Hilden, Joanne M.
Watterson, Jan
Moore, Caron
Weeks, Jane C.
Wolfe, Joanne
机构
[1] Dana Farber Canc Inst, Ctr Outcomes & Policy Res, Boston, MA 02115 USA
关键词
D O I
10.1200/JCO.2007.15.6059
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Previous literature suggests that parents often wish to continue cancer-directed therapy for their children with incurable cancer. We assessed parents' experiences with treatment for their children with cancer and no realistic chance of cure. Patients and Methods We administered questionnaires to 141 parents of children with cancer who died after receiving care at one of two cancer centers. Parents were asked whether the child benefited and suffered from treatment administered after the parent recognized that cure was not a realistic expectation, and whether they would recommend cancer-directed therapy to other families of children with advanced cancer. Results Fifty-three (38%) of 141 children received cancer-directed therapy after the parent recognized that the child had no realistic chance for cure. Most of these parents felt that their child had experienced at least some suffering resulting from the therapy (61%, 31 of 51) and little to no benefit (57%, 29 of 51). Fifty-one (38%) of 135 parents overall would recommend standard chemotherapy and 46 (33%) of 140 would recommend experimental chemotherapy to families of children with advanced cancer. Even parents who would not recommend standard chemotherapy generally felt the physician should offer it (91%, 88 of 97). Parents who reported that their children experienced suffering resulting from cancer-directed therapy ( odds ratio = 0.46; P = .02) were less likely to recommend standard chemotherapy to other families. Conclusion Although many parents choose treatment for their children with incurable cancer, bereaved parents often would not recommend such therapy. Parents who felt their children suffered as a result of cancer treatment were particularly unlikely to recommend it.
引用
收藏
页码:4759 / 4764
页数:6
相关论文
共 32 条
  • [1] Response of recurrent medulloblastoma to low-dose oral etoposide
    Ashley, DM
    Meier, L
    Zalduondo, FM
    Friedman, HS
    Gajjar, A
    Kun, L
    Duffner, PK
    Smith, S
    Longee, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (06) : 1922 - 1927
  • [2] Understanding parents' approaches to care and treatment of children with cancer when standard therapy has failed
    Bluebond-Langner, Myra
    Belasco, Jean Bello
    Goldman, Ann
    Belasco, Carmen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (17) : 2414 - 2419
  • [3] The aggressiveness of cancer care in the last three months of life: A retrospective single centre analysis
    Braga, Sofia
    Miranda, Ana
    Fonseca, Rute
    Passos-Coelho, J. L.
    Fernandes, Aires
    Costa, J. D.
    Moreira, Antonio
    [J]. PSYCHO-ONCOLOGY, 2007, 16 (09) : 863 - 868
  • [4] Ifosfamide/carboplatin/etoposide (ICE) as front-line, topotecan/cyclophosphamide as second-line and oral temozolomide as third-line treatment for advanced neuroblastoma over one year of age
    Donfrancesco, A
    Jenkner, A
    Castellano, A
    Ilari, I
    Milano, GM
    De Sio, L
    Cozza, R
    Fidani, P
    Deb, G
    De Laurentis, C
    Inserra, A
    Dominici, C
    [J]. ACTA PAEDIATRICA, 2004, 93 : 6 - 11
  • [5] Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer
    Doyle, C
    Crump, M
    Pintilie, M
    Oza, AM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) : 1266 - 1274
  • [6] Trends in the aggressiveness of cancer care near the end of life
    Earle, CC
    Neville, BA
    Landrum, MB
    Ayanian, JZ
    Block, SD
    Weeks, JC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (02) : 315 - 321
  • [7] Chemotherapy use among medicare beneficiaries at the end of life
    Emanuel, EJ
    Young-Xu, Y
    Levinsky, NG
    Gazelle, G
    Saynina, O
    Ash, AS
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 138 (08) : 639 - 643
  • [8] Understanding the treatment preferences of seriously ill patients
    Fried, TR
    Bradley, EH
    Towle, VR
    Allore, H
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (14) : 1061 - 1066
  • [9] MORTALITY IN PEDIATRIC PHASE-I CLINICAL-TRIALS
    FURMAN, WL
    PRATT, CB
    RIVERA, GK
    KRISCHER, JP
    KAMEN, BA
    VIETTI, TJ
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (15) : 1193 - 1194
  • [10] Use of chemotherapy at the end of life in a Portuguese oncology center
    Goncalves, Jose Ferraz
    Goyanes, Carmen
    [J]. SUPPORTIVE CARE IN CANCER, 2008, 16 (04) : 321 - 327